Wanted: “Imaginative and Original Thoughts” On Coverage With Evidence Development
This article was originally published in RPM Report
Executive Summary
The Centers for Medicare & Medicaid Services is revisiting its policy on Coverage with Evidence Development. Here is how two key officials from CMS’ Coverage & Analysis Group described their thinking during a conversation with The RPM Report as part of the FDA/CMS Summit for Biopharma Executives in December.